Genome-informed drug use for cardiovascular diseases in the UAE: The first prospective PGx clinical study in the Middle East and SE Asia
G2MC News and Events Genome-informed drug use for cardiovascular diseases in the UAE: The first prospective PGx clinical study in the Middle East and SE Asia Pharmacogenomics (PGx) aims to reduce the ‘trial and error’ prescribing, leading to more efficacious, safer and cost-effective drug therapies. One of the most prominent applications is in cardiovascular diseases … Read more